<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02601508</url>
  </required_header>
  <id_info>
    <org_study_id>CNUHH-2015-135</org_study_id>
    <nct_id>NCT02601508</nct_id>
  </id_info>
  <brief_title>Compare of Surgical Condition and Complications With Moderate and Deep NM Block</brief_title>
  <acronym>MISPCNUHH</acronym>
  <official_title>A Randomized, Parallel Design, Single-center Study to Compare of Surgical Condition and Postoperative Complications With Moderate and Deep Neuromuscular Blockade in Laparoscopic Gastrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chonnam National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chonnam National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to evaluate the surgeon's satisfaction with either deep or moderate
      neuromuscular blockade during laparoscopic gastrectomy surgery and observe the recovery
      profiles in the recovery room and the ward.The explorative objective of this study is to
      evaluate the safety profiles of deep and moderate neuromuscular blockades via observation of
      postoperative complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neuromuscular blocking agents (NMBAs) are frequently using during anesthesia to facilitate
      tracheal intubation and to improve surgical conditions. In an adequately anesthetized and
      monitored patient, the presence of one or two responses in the train-of-four (TOF) pattern
      normally indicates sufficient relaxation for most surgical procedures in general practices.
      It has been called moderate neuromuscular blockade (mNMB) condition. Nowadays, laparoscopic
      surgeries have expanded impressively into various areas of surgeries, both in scope and
      volume. If any hypothetical advantages of deep neuromuscular blockade (dNMB) during
      laparoscopic surgery turned out to be realized in practice with sufficient supporting
      evidence, it would become an important anesthetic option for better patient outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical rating SCORE(SRS)</measure>
    <time_frame>every 15 minutes from the pneumoperitoneum, up to 120 minutes till the end of surgery</time_frame>
    <description>excellent (5), good but not optimal (4), moderate (3), poor but acceptable (2) or poor and unacceptable (1)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate</measure>
    <time_frame>every 15 minutes from the arrival on the recovery room, up to 60 minutes</time_frame>
    <description>Respiratory rate of patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>peripheral arterial oxygen saturation</measure>
    <time_frame>every 15 minutes from the arrival on the recovery room, up to 60 minutes</time_frame>
    <description>peripheral arterial oxygen saturation(sPO2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analogue scale (VAS) for pain</measure>
    <time_frame>every 15 minutes from the arrival on the recovery room, up to 60 minutes</time_frame>
    <description>visual analogue scale (VAS) for pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurrence of nausea or vomiting</measure>
    <time_frame>every 15 minutes from the arrival on the recovery room, up to 60 minutes</time_frame>
    <description>occurrence of nausea or vomiting with Rhodes Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the level of sedation or alertness</measure>
    <time_frame>every 15 minutes from the arrival on the recovery room, up to 60 minutes</time_frame>
    <description>the level of sedation or alertness with OAA/S scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Quality Recovery Scale (PQRS)</measure>
    <time_frame>at baseline (the day before surgery), at 1 hour after surgery, at 6 hours after surgery, at 24 hours after surgery and at 7 days after surgery</time_frame>
    <description>physiologic, nociceptive, emotive, cognitive and activities of daily living</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Neuromuscular Blockade</condition>
  <arm_group>
    <arm_group_label>Modarate Blockade Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Neuromuscular blocking agent, cis-atracurium will be administered after skin incision and reversal agents, pyridostigmine &amp; glycopyrrolate will be given for the recovery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Deep Blockade Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Neuromuscular blocking agent, rocuronium will be administered after skin incision and reversal agent, Sugammadex will be given for the recovery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium</intervention_name>
    <description>Continuous infusion of rocuronium for PTC 1 + Sugammadex</description>
    <arm_group_label>Deep Blockade Group</arm_group_label>
    <other_name>Esmeron®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cis-atracurium</intervention_name>
    <description>Intermittent injection of cis-atracurium for TOF 1 + Pyridostigmine &amp; Glycopyrrolate</description>
    <arm_group_label>Modarate Blockade Group</arm_group_label>
    <other_name>Nimbex®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult (≥ 20 years of age) patients scheduled for an elective laparoscopic
             gastrectomy who have signed the written informed consent.

        Exclusion Criteria:

          -  Known allergy to rocuronuim, cisatracurium or sugammadex

          -  Significant liver or kidney dysfunction

          -  Any neuromuscular disease

          -  Pregnant or breast feeding

          -  Indication for rapid sequence induction

          -  Inability to give informed consent

          -  Patients taking any medication with potential interference with neuromuscular
             transmission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SEONGWOOK JEONG, MD, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chonnam University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>SEONGHEON LEE, MD, PhD</last_name>
    <phone>+82-10-8612-9548</phone>
    <email>headheadhead@naver.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shiyoung JEONG, MD</last_name>
    <phone>+82-10-9440-8415</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chonnam University Hwasun Hospital</name>
      <address>
        <city>Hwasun</city>
        <zip>519-763</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chanhong Park, BsC</last_name>
      <phone>+82-61-379-7598</phone>
      <email>cnuhpch@naver.com</email>
    </contact>
    <investigator>
      <last_name>Seongheon Lee, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Inje Kim, BsC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shi Young Chung, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Seongwook Jeong, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2015</study_first_submitted>
  <study_first_submitted_qc>November 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2015</study_first_posted>
  <last_update_submitted>November 8, 2015</last_update_submitted>
  <last_update_submitted_qc>November 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chonnam National University Hospital</investigator_affiliation>
    <investigator_full_name>Seongwook Jeong</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>deep NM block</keyword>
  <keyword>Surgeon's satisfaction</keyword>
  <keyword>bridion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Atracurium</mesh_term>
    <mesh_term>Cisatracurium</mesh_term>
    <mesh_term>Neuromuscular Blocking Agents</mesh_term>
    <mesh_term>Glycopyrrolate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

